|
US5118428A
|
|
Method to remove red blood cells from whole blood samples
|
|
US4943522A
|
|
Lateral flow, non-bibulous membrane assay protocols
|
|
CA1313616C
|
|
Lateral flow, non-bibulous membrane protocols
|
|
EP0282192A1
|
|
Competitive immunoassay for haptens using protein-hapten coupled solid phase
|
|
AU7033787A
|
|
Enzyme immunoassay device
|
|
CA1309558C
|
|
D-gl conjugate therapy
|
|
ES8705760A1
|
|
Prepn. of T-human cell hybridoma conveying allergy-suppressing factor
|
|
ES8702492A1
|
|
Allergy-suppressing factor prodn.
|
|
ES8702491A1
|
|
Allergy-suppressing factor prodn.
|
|
ES8900027A1
|
|
Detection and determn. of allergy suppressive factor
|
|
AU4714285A
|
|
Assay for drugs of abuse
|
|
AU3750685A
|
|
Assay for strep a using protected antibodies
|
|
PT79507A
|
|
Supressive factor of allergy
|
|
PT79504A
|
|
Detection of human chorionic gonadotropin
|
|
PT79506A
|
|
T-cell growth factor
|
|
PT79505A
|
|
Protection of antibody during chemical modification
|
|
DK346584D0
|
|
Immunity analysis unit
|
|
EP0154625A1
|
|
Hybridoma cell line producing suppressive factor of allergy.
|
|
EP0140896A1
|
|
Protection of antibody during chemical modification
|
|
AU2346684A
|
|
Removal of self-binding and staph a cross-reactivity of anti-strep antibody
|
